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oxidation with glycolysis only under hypoxic conditions. This 
indicates that adenocarcinomas exhibit glycolysis under 
normoxic conditions, whereas squamous cell carcinomas are 
exposed to diffusion-limited hypoxia resulting in a very high 
anaerobic glycolytic rate. Consequently, FDG-PET should be 
interpreted in relation to histology. The FDG PET 
interpretation based on histology improves its prognostic and 
predictive potential prior to treatment and allows monitoring 
of treatment efficacy during treatment. 
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Imaging biomarkers are defined as objective characteristics 
extracted from medical images that are related to normal 
biological processes, diseases, or the response to treatment. 
Imaging biomarkers evaluate the in vivo properties by in 
silico modelling of different tissue and lesion properties. 
These patient specific features are resolved in space 
(parametric images) and time (longitudinal changes), and can 
be compared to normal population based data.  
To develop an imaging biomarker, it is necessary to carry out 
a series of steps to evaluate reproducibility, technical 
standardization, validation of the relationship with the 
studied object and situation, and finally checking its clinical 
meaningfulness. This process includes defining proofs and 
tests for the concepts and mechanisms; obtaining 
standardized and optimized anatomic, functional, and 
molecular images in a multimodality approach; analyzing 
reconstructed data with computer and statistical models; 
displaying the parameterized data appropriately; obtaining 
the different statistic measures and histogram distribution; 
and finally conducting tests on the principle, efficacy, and 
effectiveness of the biomarker.  
To further develop this strategy, medical imaging biobanks 
with oncology data are needed. These virtual biobanks 
recently emerged for advancing on the study of rare diseases, 
the identification of early biomarkers and surrogates, and the 
development of population studies. 
Oncologic imaging biobanks will evaluate the impact of new 
biomarkers on early disease diagnosis, disease phenotyping, 
disease grading, targeting therapies and evaluation of disease 
response to treatment.In this presentation, I aim to explain 
the steps that must be established to enable oncologic 
biomarkers to be correctly applied, from their theoretical 
conception to their clinical implementation. The learning 
objectives are:  
 To recognize the qualitative and quantitative 
information of the different modalities. 
 To learn about the commonly applied imaging tools 
in assessing neoplasm size, volume and extension. 
 To know the current applied method for 
quantification of tumor aggressiveness and 
response to treatment.  
 To go through a critical review of criteria actually 
used in oncologic stratification and management. 
 To become familiar with the most appropriate 
functional imaging biomarkers of tumor activity 
(perfusion, diffusion, oxygen).  
 To appreciate the clinical role of these techniques 
in planning therapeutic strategies. 
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Purpose/Objective: Combined PET/MRI may be highly 
beneficial for the individualization of radiotherapy (RT) due 
to the provided anatomical, molecular and functional 
information. The purpose of this study was to perform a 
correlation analysis of functional PET/MR images in head and 
neck (HN) tumors. Functional imaging data comprised 
apparent diffusion coefficient (ADC) maps from diffusion-
weighted (DW)-MRI, dynamic contrast-enhanced (DCE)-MRI 
and FDG as well as FMISO-PET. 
Materials and Methods: N=8 HN patient datasets from 
combined FDG-PET/MRI (n=8 STIR, i.e. anatomical T2w MRI; 
n=8 ADC) acquired 1h post injection (p.i.) as well as M=7 HN 
patient datasets from combined FMISO-PET/MRI (m=7 STIR; 
m=7 ADC; m'=5 DCE) acquired 3h post p.i. were available. 
Moreover, for each FMISO-PET/MR patient also an FDG-
PET/CT dataset was available. For the FDG-PET/MR patients, 
tumor volumes were manually defined by a radiation 
oncologist based on FDG as well as STIR images. For the 
FMISO-PET/MR patients, tumor volumes were transferred 
from the planning CT to the PET/MR datasets by deformable 
registration, using the STIR image as reference. Similarly, the 
FDG-PET/CT data was transferred to the FMISO-PET/MR 
datasets by deformable registration. From the DCE data, 
parametric maps were derived according to the extended 
Tofts model, yielding the volume transfer constant Ktrans as 
well as the extravascular, extracellular fraction ve and the 
blood plasma fraction vp. For each patient, voxel-based 
correlations within the tumor were assessed by Spearman 
coefficients for all possible pairs of functional data and 
parameter maps. Two ADC datasets from FMISO-PET/MRI 
were excluded from the analysis due to geometrical 
distortions. 
Results: For each of the pairwise combinations of functional 
parameters, obtained Spearman correlation coefficients 
varied strongly between patients. Resulting median 
correlation coefficients of the patient cohort are shown in 
Table 1. Highest correlations were observed for the 
combinations ve/Ktrans (median: 0.58; range: 0.49 - 0.84), 
FDG/FMISO (0.57; 0.09 - 0.79), ADC/FDG (-0.38; -0.85 - 
0.15), ve/vp (0.36; 0.23 - 0.61), Ktrans/FDG (0.31; 0.11 - 0.59) 
and ADC/FMISO (-0.31; -0.72 - 0.2). 
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Conclusions 
Functional PET and MR data showed an incoherent picture of 
correlations between different parameters, indicating 
complementary information. While only weak correlations 
were observed in the median over all datasets, distinct 
correlations were present on an individual basis. For the 
combinations FDG/FMISO and ADC/FDG correlations up to -
0.79 and -0.85 were observed, respectively. However, 
limitations may arise from the low number of patients and 
differences in tumor localization and stage. More patient 
data is needed to clarify whether subgroups of HN tumors can 
be identified for which parameter correlations exist. 
Moreover, in a further step potential correlations between 
three or more datasets need to be analyzed. 
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Purpose/Objective: In personalized medicine, early 
prediction of response to chemo-radiotherapy (CRT) in locally 
advanced rectal cancer (LARC) is essential to tailor 
treatment. Radiomics, a high throughput approach to extract 
and mine a large number of quantitative features from 
medical images, may be of added value. This study aimed to 
investigate and independently validate the predictive value 
of radiomic features derived from pre-treatment 18F-FDG 
PET images for pathological tumor stage (ypTN) after 
preoperative CRT in LARC. 
Materials and Methods: As training cohort, 324 LARC patients 
accrued at our institute between 2005 and 2011 (NIH 
registered), were included. As validation cohort, 57 LARC 
patients accrued between 2009 and 2011 at an external 
institute (NIH registered) were included. Patients received 
CRT, followed by total mesorectal excision. Patients 
underwent 18F-FDG PET imaging at baseline (Figure 1a). The 
tumor volume was semi-automatically delineated with a 
signal to background based SUV threshold. In total, 166 
radiomic features were extracted, comprising: I) first-order 
statistics (stats) (N=15), II) intensity volume histogram (IVH) 
(N=95), III) shape (N=11), and IV) texture (N=44). Based on 
review of the resected specimen, patients were grouped into 
responders (ypT012N0) and non-responders (ypT2+N0+). First, 
the feature space was reduced by (1) selecting features that 
are stable in both a test-retest and inter-observer setting 
(determined in other cohorts) and (2) correlation based 
hierarchical cluster analysis. Logistic regression was used for 
predictive modelling and model performance was defined as 
the area under the receiver operating characteristic curve 
(AUC). The most predictive features were identified in the 
training cohort, using a cross-validated forward feature 
selection scheme. The out-of-sample model performance in 
the training cohort was determined using 100 rounds of 10-
fold stratified cross-validation, followed by independent 
external validation. 
